Post Market Registry Study of Intracranial Aneurysms Treated With Sugita Clipping Devices
Key facts
- Where
- Essen, GermanySee the site
Where in Germany
- Universitätsklinikum EssenEssen, GermanyContact: Ulrich Sure, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Mizuho Corporation
- Trial code
- NCT06798740
- Record updated
- 9 February 2026
- Original description
The objective of this study is to verify the performance and safety of the Sugita Aneurysm Clips devices when used as intended and to identify possible risk factors. Data collected will be used to support the continuing performance and safety of the devices in the post-market use environment in Europe. Subjects who have an intracranial aneurysm that the physician intends to treat with the subject devices will be included in the study. Subjects will be followup as per hospital standard of care for 5 years.Read full original descriptionShow less
The objective of this study is to verify the performance and safety of the Sugita Aneurysm Clips devices when used as intended and to identify possible risk factors. Data collected will be used to support the continuing performance and safety of the devices in the post-market use environment in Europe. Subjects who have an intracranial aneurysm that the physician intends to treat with the subject devices will be included in the study. Subjects will be followup as per hospital standard of care for 5 years.
Inclusion: Subject has an intracranial aneurysm (ruptured or unruptured) that can be treated with one of the proposed devices; Subject is adult, ≥18 years; As per national regulations, subject or subject's legally authorized representative (LAR) has signed written informed consent; Subject is willing to comply with scheduled visits and examinations per institutional standard of care.
Exclusion: Subject is currently enrolled in or plans to be enrolled in a concurrent drug or device randomized study; Subject has a condition which will not allow him/her to comply with his/her post-procedure follow up per the institutional standard of care (medical condition, subject living abroad and unable to return for follow- up, e.g.); Subject is a child, <18 years; Subject does not meet IFU criteria of the subject device.